Skip to main content

Abstract

The non-motor symptoms (NMSs) of Parkinson’s disease (PD) remain an under-recognized and, consequently, under-treated set of symptoms. There is a wide variety of NMSs, ranging from neuropsychiatric and autonomic dysfunction to sleep disturbance and other symptoms. Figure 1.1 outlines the NMS complex of PD. Some NMSs can be related to dopaminergic treatment, such as dopamine dysregulation syndrome, drug-induced hallucinations or psychosis, and postural hypotension, whereas fluctuations in motor responses may also have major non-motor components— the so—called non-motor fluctuation [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006;5:235-245.

    Google Scholar 

  2. Martinez-Martin P, Schapira AH, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007;22:1623-1629.

    Google Scholar 

  3. Chaudhuri KR, Schapira AHV. The non motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-474.

    Google Scholar 

  4. Zgaljardic DJ, Foldi NS, Borod JC. Cognitive and behavioral dysfunction in Parkinson’s disease: neurochemical and clinicopathological contributions. J Neural Transm 2004;111:1287-1301.

    Google Scholar 

  5. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003;24:197-211.

    Google Scholar 

  6. Del Tredici K, Braak H. Idiopathic Parkinson’s disease: staging an α-synucleinopathy with a predictable pathoanatomy. In: Kahle P, Haass C (eds), Molecular Mechanisms in Parkinson’s Disease. Georgetown, TX: Landes Bioscience, 2004:1-32.

    Google Scholar 

  7. Hawkes C, Del Tredici K, Braak H. Parkinson’s disease: a dual hit hypothesis. Neuropath Appl Neurobiol 2007;33:599-614.

    Google Scholar 

  8. Willis GL. Parkinson ‘s disease as a neuro-endocrine disorder of circadian function: dopamine melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 2008;19:245-316.

    Google Scholar 

  9. Hely MA, Reid WG, Adena MA, et al. The Sydney multicenter study of Parkinson’s disease: the inevitability of dementia at 20 years. Mov Disord 2008;23:837-844.

    Google Scholar 

  10. Global Parkinson’s Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson’s disease: results from an international survey. Mov Disord 2002;17:60-67.

    Google Scholar 

  11. Lohle M, Storch A, Reichmann H. Beyond tremor and rigidity: non-motor features of Parkinson’s disease. J Neural Transm 2009;116:1483-1492.

    Google Scholar 

  12. Chaudhuri K, Martinez-Martin P, Brown R. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Mov Disord 2007;22:1901-1911.

    Google Scholar 

  13. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009;73:1584-1591.

    Google Scholar 

  14. Qin Z, Zhang L, Sun F, et al. Health related quality of life in early Parkinson’s disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 2009;15:767-771.

    Google Scholar 

  15. Qin Z, Zhang L, Sun F, et al. Depressive symptoms impacting on health-related quality of life in early Parkinson’s disease: results from Chinese l-dopa exposed cohort. Clin Neurol Neurosurg 2009b;111:733-737.

    Google Scholar 

  16. Carter JH, Stewart BJ, Lyons KS, Archbold PG. Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression? Mov Disord 2008;23:1211-1216.

    Google Scholar 

  17. Keranen T, Kaakkola S, Sotaniemi K, et al. Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord 2003;9:163-168.

    Google Scholar 

  18. Chaudhuri KR, Yates L, Martinez-Martin P. The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005;5:275-283.

    Google Scholar 

  19. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord 2002;8:193-197.

    Google Scholar 

  20. Grosset D, Taurah L, Burn DJ, et al. A multicentre longitudinal observational study of changes in self reported health status in people with Parkinson’s disease left untreated at diagnosis. J Neurol Neurosurg Psychiatry 2007;78:465-469.

    Google Scholar 

  21. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson’s disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 2010;25:697-701.

    Google Scholar 

  22. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 2006;21: 916-923.

    Google Scholar 

  23. Chaudhuri KR, Martinez-Martin P. Quantitation of non-motor symptoms in Parkinson’s disease. Eur J Neurol 2008;15(suppl 2):2-7.

    Google Scholar 

  24. Scottish Intercollegiate Guidelines Network. Diagnosis and pharmacological management of Parkinson’s disease. Available online at www.sign.ac.uk/pdf/sign113.pdf. Last accessed August 2011.

  25. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Mov Disord 2007;22:1901-1911.

    Google Scholar 

  26. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.

    Google Scholar 

  27. Trenkwalder C, Chaudhuri K, Anderson TB, et al; for the RECOVER Study Group. Effect of rotigotine on control of early morning motor function and sleep quality in subjects with idiopathic Parkinson’s disease. Parkinsonism Relat Disord 2009;15(suppl 136):2.170.

    Google Scholar 

  28. Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010;74:924-931.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Healthcare, a part of Springer Science+Business Media

About this chapter

Cite this chapter

Mitra, M.T., Chaudhuri, K.R. (2011). Introduction. In: Handbook of Non-Motor Symptoms in Parkinson's Disease. Springer Healthcare, Heidelberg. https://doi.org/10.1007/978-1-908517-60-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-908517-60-9_1

  • Published:

  • Publisher Name: Springer Healthcare, Heidelberg

  • Print ISBN: 978-1-907673-23-8

  • Online ISBN: 978-1-908517-60-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics